F/M Emr Life Sciences in ETFLFSCETF
13F holders, Q1 2025 (March 31)4holders +2
3new positions
1sold out
$22.40avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding F/M Emr Life Sciences in ETF (LFSC) in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were Hunter Associates Investment Management LLC ($820K), Mirae Asset Securities (usa) Inc. ($298K) and Parkside Financial Bank & Trust ($27K).
- Company
- F/M Emr Life Sciences in ETF
- Filed as
- RBB FD INC (Q1 2025)
- CUSIP
- 74933W221
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $325K |
| Exits | 1 | $46.7M |
All 13F filers, Q4 2024 → Q1 2025: 25,804 shares bought and 1,997,035 shares sold, net −1,971,231 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Hunter Associates Investment Management LLC | 0.13% | Add +44.8% | 36,639 | $820K |
| Mirae Asset Securities (usa) Inc. | 0.01% | New | 13,252 | $298K |
| Parkside Financial Bank & Trust | 0.00% | New | 1,215 | $27K |
| UBS Group AG | 0.00% | New | 8 | $180 |
"% of holder's portfolio" is LFSC's weight in each manager's 13F, not the share of F/M Emr Life Sciences in ETF the manager owns.